| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $540.7M | +13.5% |
| Cost of Revenue | $215.9M | +12.7% |
| Gross Profit | $324.8M | +13.9% |
| R&D Expense | $129.4M | +10.3% |
| SG&A Expense | $90.3M | +17.6% |
| Operating Income | -$18.1M | +54.1% |
| Pre-tax Income | -$35.6M | +15.2% |
| Income Tax | -$2.5M | -257.9% |
| Net Income | -$37.9M |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $120.9M | +7.9% |
| Accounts Receivable | $146.8M | +29.9% |
| Current Assets | $302.2M | +20.5% |
| Total Assets | $1.61B | +20.1% |
| Current Liabilities | $251.5M | +17.0% |
| Total Liabilities | $512.8M | +78.2% |
| Stockholders' Equity | $1.09B | +3.8% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $55.2M | -3.6% |
| Capital Expenditures | $1.8M | -48.3% |
| Investing Cash Flow | -$219.2M | -3363.6% |
| Financing Cash Flow | $170.5M | +907.5% |
| Free Cash Flow | $53.4M | -0.7% |
| +10.6% |
| EPS (Basic) | -$0.33 | +13.2% |
| EPS (Diluted) | -$0.33 | +13.2% |